Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Inflammatory response in Parkinson's disease (Review)

Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G.

Mol Med Rep. 2014 Nov;10(5):2223-33. doi: 10.3892/mmr.2014.2563. Epub 2014 Sep 12.

The transcription factor X-box binding protein-1 in neurodegenerative diseases

Dunys J, Duplan E, Checler F.

Mol Neurodegener. 2014 Sep 12;9:35. doi: 10.1186/1750-1326-9-35.

Smoking and Parkinson disease: where there is smoke there may not be fire

Hershey LA, Perlmutter JS.

Neurology. 2014 Oct 14;83(16):1392-3. doi: 10.1212/WNL.0000000000000896. Epub 2014 Sep 12.

Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies

Goedert M, Falcon B, Clavaguera F, Tolnay M.

Curr Neurol Neurosci Rep. 2014 Nov;14(11):495. doi: 10.1007/s11910-014-0495-z.

The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans

Liu P, Li X, Li FF, Ou-Yang QH, Zhang HX, Feng T.

Neurosci Lett. 2014 Oct 17;582:99-103. doi: 10.1016/j.neulet.2014.08.053. Epub 2014 Sep 10.

mTOR and the health benefits of exercise

Watson K, Baar K.

Semin Cell Dev Biol. 2014 Dec;36:130-9. doi: 10.1016/j.semcdb.2014.08.013. Epub 2014 Sep 16.

Shoulder tendinopathy causing inflammation surrounding pulse generator after DBS

Lefaucheur R, Maltête D, Bouwyn JP, Borden A, Gilard V, Wallon D, Derrey S.

Parkinsonism Relat Disord. 2014 Nov;20(11):1304-6. doi: 10.1016/j.parkreldis.2014.08.018. Epub 2014 Sep 1.

Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects

Li M, Shi A, Pang H, Xue W, Li Y, Cao G, Yan B, Dong F, Li K, Xiao W, He G, Du G, Hu X.

J Ethnopharmacol. 2014 Oct 28;156:210-5. doi: 10.1016/j.jep.2014.08.031. Epub 2014 Sep 8.

[Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: a case report]

Meriç C, Pirdoğan E, Günday Toker Ö, Tekin A, Bakım B, Çelik S.

Turk Psikiyatri Derg. 2014 Fall;25(3):212-4.

Immune responses in neurodegenerative diseases

Shrestha R, Shakya Shrestha S, Millingtona O, Brewer J, Bushell T.

Kathmandu Univ Med J (KUMJ). 2014 Jan-Mar;12(45):67-76. doi: 10.3126/kumj.v12i1.13646.

Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites

Stroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA.

Mov Disord. 2014 Nov;29(13):1666-74. doi: 10.1002/mds.26029. Epub 2014 Sep 15.

Osteoporosis in neurodegeneration

Roos PM.

J Trace Elem Med Biol. 2014 Oct;28(4):418-21. doi: 10.1016/j.jtemb.2014.08.010. Epub 2014 Aug 29.

VMAT2 and Parkinson's disease: harnessing the dopamine vesicle

Lohr KM, Miller GW.

Expert Rev Neurother. 2014 Oct;14(10):1115-7. doi: 10.1586/14737175.2014.960399. Epub 2014 Sep 14.

Initial medication in patients of newly diagnosed Parkinson's disease in Taiwan

Guo YJ, Liao YC, Lin CH, Chang MH.

PLoS One. 2014 Sep 15;9(9):e107465. doi: 10.1371/journal.pone.0107465. eCollection 2014.

Resolution of Othello Syndrome After Subthalamic Nucleus Deep Brain Stimulation in 3 Patients with Parkinson's Disease

Adam RJ, McLeod R, Ha AD, Colebatch JG, Menzies G, de Moore G, Mahant N, Fung VSC.

Mov Disord Clin Pract. 2014 Sep 16;1(4):357-360. doi: 10.1002/mdc3.12084. eCollection 2014 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias